# OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

> **NCT00900302** · — · COMPLETED · sponsor: **OHSU Knight Cancer Institute** · enrollment: 98 (actual)

## Conditions studied

- Cancer

## Interventions

- **GENETIC:** protein expression analysis
- **OTHER:** immunohistochemistry staining method
- **OTHER:** laboratory biomarker analysis
- **PROCEDURE:** biopsy

## Key facts

- **NCT ID:** NCT00900302
- **Lead sponsor:** OHSU Knight Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2016-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00900302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00900302, "OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00900302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*